https://thenationaldesk.com/news/fact-check-team/what-is-ketamine-drug-matthew-perry-autopsy-report-fda-approval-depression-anxiety-substance-abuse-treatment-disorders-orally-nasal-spray-infusions-clinical-setting-research-illegal-distribution
In 2019, the FDA approved ketamine infusions to treat depression and anxiety, and it has also been prescribed to treat substance-use disorders.
Create an account or login to join the discussion